1. Home
  2. PRPH vs BSLK Comparison

PRPH vs BSLK Comparison

Compare PRPH & BSLK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRPH
    SELLHOLDBUYas of 8 hours ago
  • BSLK
    SELLHOLDBUYas of 2024 years ago
  • Stock Information
  • Founded
  • PRPH 1989
  • BSLK 2009
  • Country
  • PRPH United States
  • BSLK United States
  • Employees
  • PRPH N/A
  • BSLK N/A
  • Industry
  • PRPH Biotechnology: Pharmaceutical Preparations
  • BSLK
  • Sector
  • PRPH Health Care
  • BSLK
  • Exchange
  • PRPH Nasdaq
  • BSLK NYSE
  • Market Cap
  • PRPH 10.7M
  • BSLK 12.3M
  • IPO Year
  • PRPH 1997
  • BSLK N/A
  • Fundamental
  • Price
  • PRPH $0.24
  • BSLK $0.27
  • Analyst Decision
  • PRPH
  • BSLK
  • Analyst Count
  • PRPH 0
  • BSLK 0
  • Target Price
  • PRPH N/A
  • BSLK N/A
  • AVG Volume (30 Days)
  • PRPH 1.9M
  • BSLK 132.7K
  • Earning Date
  • PRPH 03-31-2025
  • BSLK 05-21-2025
  • Dividend Yield
  • PRPH N/A
  • BSLK N/A
  • EPS Growth
  • PRPH N/A
  • BSLK N/A
  • EPS
  • PRPH N/A
  • BSLK N/A
  • Revenue
  • PRPH $6,770,000.00
  • BSLK $1,373,000.00
  • Revenue This Year
  • PRPH N/A
  • BSLK N/A
  • Revenue Next Year
  • PRPH $64.06
  • BSLK N/A
  • P/E Ratio
  • PRPH N/A
  • BSLK N/A
  • Revenue Growth
  • PRPH N/A
  • BSLK N/A
  • 52 Week Low
  • PRPH $0.22
  • BSLK $0.23
  • 52 Week High
  • PRPH $7.48
  • BSLK $17.02
  • Technical
  • Relative Strength Index (RSI)
  • PRPH 32.48
  • BSLK N/A
  • Support Level
  • PRPH $0.35
  • BSLK N/A
  • Resistance Level
  • PRPH $0.52
  • BSLK N/A
  • Average True Range (ATR)
  • PRPH 0.09
  • BSLK 0.00
  • MACD
  • PRPH -0.01
  • BSLK 0.00
  • Stochastic Oscillator
  • PRPH 1.02
  • BSLK 0.00

Stock Price Comparison Chart: PRPH vs BSLK

PRPH
BSLK
JulyOctober2022AprilJulyOctober2023AprilJulyOctober2024AprilJulyOctober2025April0246810121416PRPH VS BSLK

About PRPH ProPhase Labs Inc. (DE)

ProPhase Labs Inc is a diversified company that offers a range of services including diagnostic testing, genomics testing and contract manufacturing. Its operating segments include Diagnostic services and Consumer products. The Diagnostic segment provides COVID-19 diagnostic information services to a broad range of customers in the United States, including health plans, third-party payers and government organizations. The Consumer products segment is engaged in the research, development, manufacture, distribution, marketing and sale of OTC consumer healthcare products and dietary supplements in the United States and also provide personal genomics products and services.

About BSLK BOLT PROJECTS HOLDINGS INC

Bolt Projects Holdings Inc formerly Golden Arrow Merger Corp is an shell company.

Share on Social Networks:

0

By browsing this website, you accept our Privacy Policy & Terms of Use